Vizimpro
Payments companies reported to CMS as associated with Vizimpro. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vizimpro, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vizimpro
These are the largest totals companies reported as associated with Vizimpro. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Bauer | Nashville, TN | Hematology & Oncology | $8,180.00 |
| Mary Grizzard | Franklin, TN | Family | $8,180.00 |
| Sai Hong Ou | Orange, CA | Hematology & Oncology | $4,480.00 |
| Rachel Sanborn | Portland, OR | Medical Oncology | $3,700.00 |
| Stephanie Mcdonald | Boston, MA | Nurse Practitioner | $3,700.00 |
| Erica Stumpf | New York, NY | Primary Care | $3,700.00 |
| Martin Dietrich | Rockledge, FL | Hematology & Oncology | $3,700.00 |
| Michael Cheng | Orange, CA | Rheumatology | $3,700.00 |
| Nathan Pennell | Cleveland, OH | Hematology & Oncology | $3,700.00 |
| Christina Baik | Seattle, WA | Medical Oncology | $3,700.00 |
Prescribed Vizimpro?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.